A new solution for energy transfer to heart pumps

- EN - DE- FR- IT
Andreas Kourouklis has received a Pioneer Fellowship from ETH Zurich to develop
Andreas Kourouklis has received a Pioneer Fellowship from ETH Zurich to develop a new cable system for heart pumps. (Photograph: Nici Lebküchner / ETH Zurich)
Roughly one in two wearers of ventricular assist devices are diagnosed with an infection. The reason for this is the thick cable for the power supply. researchers have now developed a solution to mitigate this problem.

For many patients waiting for a donor heart, the only way to live a decent life is with the help of a pump attached directly to their heart. This pump requires about as much power as a TV, which it draws from an external battery via a seven-millimetre-thick cable. The system is handy and reliable, but it has one big flaw: despite medical treatment, the point at which the cable exits the abdomen can be breached by bacteria.

ETH Zurich researcher and engineer Andreas Kourouklis is working to soon make this problem a thing of the past. With the support of ETH Zurich Professor Edoardo Mazza and physicians from the German Heart Centre in Berlin, Kourouklis has developed a new cable system for heart pumps that doesn’t cause infections. This is particularly important given that wireless methods of transmitting power remain unavailable to patients in the foreseeable future. Kourouklis has received a Pioneer Fellowship from ETH Zurich to advance his technology.

Thin wires with craters instead of a thick cable

"The thick cable used in existing ventricular assist systems creates an open wound that doesn’t heal and severely compromises patients’ quality of life", Kourouklis says. Scar tissue with a limited blood supply forms around the exit point. This not only impairs the skin’s ability to heal itself but also increases the risk of infection. Since the outer layers of the skin are wounded and loosely attached to the flat surface of the thick cable, they grow in downwards. As a result, bacteria can travel from the surface of the skin into deeper tissue layers, often leading to patients having to struggle with infections and rehospitalisation.

The researchers have come up with a technology to remedy the situation. Instead of powering the heart pump via a thick cable that is much stiffer than human skin, they use several thin and flexible wires with a rough, irregular surface. Kourouklis and his team compare their approach with the way in which human hair breaks through the skin without causing infections: "More flexible wires whose surface is full of microscopic craters help the skin heal," Kourouklis says. The reason for this is that the outermost layers of skin adhere better to these wires and don’t grow inwards. New tissue forms more quickly, and the skin is more likely to remain intact as a barrier against bacterial infection.

Water drops create tiny craters

To create craters on the cables’ surface, a team of engineers led by Kourouklis and Mazza have developed a new process that allows the creation of very small, irregular patterns on surfaces that are not flat - something that had not been possible before.

This method, which is currently patented at ETH Zurich, entails coating the flexible cables with a thin silicone layer and cooling them to minus 20 degrees Celsius. The surface of the cables thus become malleable. They are then put into a condensation chamber, where small droplets of water are pressed into the liquid layer of silicone, creating microscopic craters. "We can control the position of the craters on the cables by adjusting the humidity and temperature in the condensation chamber," Kourouklis says.

The challenge here is that the craters can’t be too large or too small: if they’re too large, bacteria may settle in them and the risk of infection increases; if they’re too small, the skin does not adhere to them and grows inwards - in which case the risk of infection also increases. A classic optimisation problem, which Kourouklis and his team tackle by means of computational and experimental methods in tissue biomechanics and biomaterials.

Initial tests confirm lower risk of infection

Kourouklis and his colleagues carried out initial tests on skin cell cultures before implanting both the old and thick cables and their new cable system in a sheep. The results make the ETH Zurich researcher optimistic: while the thick cables with a flat surface caused severe inflammation, the thin, flexible cables only showed mild inflammatory reactions. No sheep suffered permanent injuries during the tests.

More important still: in contrast to the thick cables, the sheep’s skin integrated better with the new cables and hardly grew inwards. Accordingly, the thin cables with craters didn’t cause infections in the animals.

Kourouklis is currently working with medical device engineers and heart surgeons to improve the cable system. His goal is to bring the technology to market as soon as possible. But before it can be used on heart patients, a series of tests on skin models, animals and eventually humans will be needed.

Pioneer Fellowship programme

The Pioneer Fellowship is a comprehensive support programme that offers innovative thinkers ideal conditions in which to launch their commercial venture. Aimed primarily at doctoral students, the programme is also open to Master’s students and postdocs. Pioneer Fellows receive a grant of CHF 150,000 over a period of 12 to 18 months in addition to extensive mentoring and training. Fellows work in the ieLab for the duration of their fellowship. Pioneer Fellowships are funded jointly by the ETH Foundation and ETH Zurich.


Kourouklis A, · Kaemmel J, · Wu X, · Potapov E, · Cesarovic N,· Ferrari A, · Starck C, · Falk V, · Mazza E. Systems of conductive skin for power transfer in clinical applications, European Biophysics Journal 51(2), doi: 10.3929/ethz-b-000505294 .

Kourouklis A, · Kaemmel J, · Wu X, · Banos M, Chanfon A, de Brot S,· Ferrari A, · Cesarovic N , Falk V, · Mazza E. Transdermal wires for improved integration in vivo, Biomaterials Advances Volume 153, October 2023, doi: external page 10.1016/j.bioadv.2023.213568 call_made.
Christoph Elhardt